Shares & Derivatives
My Thoughts on Jinxin Fertility and XIRR Update
By Scg8866t Stockinvesting  •  November 27, 2020
Please click and read this disclaimer if you wish to continue with the contents below. JXR is a leading ARS(Assisted Reproductive Service) provider in China and the United States. It is the largest privately owned ARS provider in China with only a 3.1% penetration rate. The growth prospect in China is substantial. JXR is one of the pioneers in the ARS industry in both China and the United States. It has consistently delivered ARS with superior success rates, which is an important benchmark in the ARS industry. The assisted reproductive medical facilities in their network in China and the United States have attained success rates higher than the national average in China and the United States, respectively, In addition, HRC Fertility had higher success rates in every age group as defined by the United States Centers for Disease Control and Prevention. They are very good at what they do. JXR is in...
Read the full article
By Scg8866t Stockinvesting
Thanks for reading my blog. I am just an ordinary Singaporean with an avid interest in technical analysis, fundamental analysis and philosophy.
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance